Adverse reactions and prognosis of Lobaplatin combined with Etoposide in the treatment of primary small cell lung cancer
Fang-fang CAO,Ju-xiang XIAO
DOI: https://doi.org/10.12037/YXQY.2017.03-09
2017-01-01
Abstract:Objective To analyze the adverse reaction and prognosis of Lobaplatin combined with Etoposide in the treatment of primary small cell lung cancer (SCLC), and to investigate the therapeutic effect and safety. Method 112 cases of newly diagnosed SCLC patients treated in the First Affiliated Hospital of Xi'an Jiao Tong University from January 2014 to January 2016 were analyzed retrospectively. According to the random number table, 112 patients were divided into observation group and control group, each of 56 cases, observation group patients were treated by Lobaplatin combined with Etoposide, control group patients were treated by Cisplatin combined with Etoposide. After 2 cycles of chemotherapy, the clinical efficacy, adverse reactions, disease progression and survival rate of the patients in the two groups were evaluated. The efficacy and safety of the two methods were compared between the two groups. Result After 2 cycles of chemotherapy, there was no significant difference in the total effective rate of observation group (71.43%) and control group (75.00%) (χ2 = 0.673, P > 0.05). There were significant differences in the incidence of nausea, vomiting, diarrhea, and graduation betwen the two groups (P < 0.05). The observation group and control group time to disease progression was (8.94±1.28) months, (9.25±1.33) months, there was no significant difference between the two groups (t = 1.265, P > 0.05); observation group and control group patients' 1 year survival rates were 66.07% (37/56), 62.50% (35/56), there was no significant difference between the two groups (χ2 = 0.275, P >0.05). Conclusion Compared with cisplatin, lobaplatin combined with etoposide in the treatment of SCLC can achieve the similar effect of the approaching period, and gastrointestinal side effects during the chemotherapy of are less, which is a kind of reliable curative effect and better safety chemotherapy, and worthy of further attention.